Company highlights financial performance, strategic initiatives, and pipeline advancements....
Clinical data confirms long-term durability of results for the Revi® System in treating overactive bladder....
Collaboration aims to enhance efficiency and improve cell quality in primary T-cell culture processes....
Offered advanced screenings throughout February to support early detection and prevention of heart disease....
The discussion highlights ExacTcell™ Technology’s potential in advancing scalable solutions for medical preparedness....
The recommended cash offer to Abliva shareholders is now unconditional, with an extended acceptance period....
Enhancing patient-centric care with advanced digital tools and analytics. ...
The world’s longest-lasting continuous glucose monitor moves closer to European market approval. ...
The collaboration aims to drive long-term brain monitoring and neurostimulation innovations into clinical applications....
Compelling opportunity expected to unlock substantial value through enhanced focus, tailored investment and capital allocation, and optimized market valuation ...
